(Q83568210)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

title

Activation of mammalian target of rapamycin pathway confers adverse outcome in nonsmall cell lung carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

1 reference

Dan Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Yi Huang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Bojiang Chen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Jing Zeng

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Na Guo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Shangfu Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Lunxu Liu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Hong Xu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Xianming Mo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Weimin Li

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

8 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

3763-3773

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

The TOR pathway: a target for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Mammalian target of rapamycin: biological function and target for novel anticancer agents

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Analysis of complex protein kinase B signalling pathways in human prostate cancer samples

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Identification of potential driver genes in human liver carcinoma by genomewide screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

From man to mouse and back again: advances in defining tumor AKTivities in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

mTOR, translation initiation and cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Current status of mammalian target of rapamycin inhibitors in lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Decrease in Akt/PKB signalling in human skeletal muscle by resistance exercise

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Inhibition of mTOR restores cisplatin sensitivity through down-regulation of growth and anti-apoptotic proteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Rationale for a phase I trial of erlotinib and the mammalian target of rapamycin inhibitor everolimus (RAD001) for patients with relapsed non small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

A Phase 1 clinical study of temsirolimus (CCI-779) in Japanese patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

The role of the Akt/mTOR pathway in tobacco carcinogen-induced lung tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

The role of targeting mammalian target of rapamycin in lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

The biology behind mTOR inhibition in sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

mTOR and P70 S6 kinase expression in primary liver neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Combination therapy targeting both tumor-initiating and differentiated cell populations in prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Overexpression of the mammalian target of rapamycin: a novel biomarker for poor survival in resected early stage non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

The potential role of mTOR inhibitors in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

PDK1: the major transducer of PI 3-kinase actions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Regulation of kinase activity of 3-phosphoinositide-dependent protein kinase-1 by binding to 14-3-3

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

PDK2: a complex tail in one Akt.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Prognostic significance of clinical factors and Akt activation in patients with bronchioloalveolar carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Targeting the translational machinery as a novel treatment strategy for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Activation of p70s6k is associated with phosphorylation of four clustered sites displaying Ser/Thr-Pro motifs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

The S6 kinase signaling pathway in the control of development and growth.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Protein expression profiles in renal cell carcinoma: staging, prognosis, and patient selection for clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Mechanism of ribosomal p70S6 kinase activation by granulocyte macrophage colony-stimulating factor in neutrophils: cooperation of a MEK-related, THR421/SER424 kinase and a rapamycin-sensitive, m-TOR-related THR389 kinase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25959

7 January 2021

Identifiers

DOI

10.1002/CNCR.25959

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387259%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference